Research ArticleCancer

Systemic cancer therapy with engineered adenovirus that evades innate immunity

See allHide authors and affiliations

Science Translational Medicine  25 Nov 2020:
Vol. 12, Issue 571, eabc6659
DOI: 10.1126/scitranslmed.abc6659

Article Information

vol. 12 no. 571

Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 6, 2020
  • Accepted for publication August 21, 2020
  • .

Author Information

  1. Svetlana Atasheva1,*,
  2. Corey C. Emerson2,*,
  3. Jia Yao1,
  4. Cedrick Young1,
  5. Phoebe L. Stewart2, and
  6. Dmitry M. Shayakhmetov1,3,4,5,
  1. 1Lowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  2. 2Department of Pharmacology and Cleveland Center for Membrane and Structural Biology, Case Western Reserve University, Cleveland, OH 44106, USA.
  3. 3Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  4. 4Emory Center for Transplantation and Immune-mediated Disorders, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
  5. 5Discovery and Developmental Therapeutics Program, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
  1. Corresponding author. Email: pls47{at}case.edu (P.L.S.); dmitryshay{at}emory.edu (D.M.S.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: November 2020 to March 2021

AbstractFullPdf
Nov 202034021000409
Dec 202026781259409
Jan 202152020990
Feb 20214625448
Mar 20214099

Stay Connected to Science Translational Medicine